SAN DIEGO, CA--(Marketwired - Feb 18, 2014) - Ivera Medical Corporation, headquartered in San Diego, CA, announced that the United States District Court for the Southern District of California has denied a motion for summary judgment filed by Catheter Connections, Inc. in Ivera Medical's lawsuit alleging that Catheter Connections infringes U.S. Patent Nos. 7,780,794 ("the '794  patent"), 7,985,302 ("the '302 patent"), and 8,206,514 ("the '514 patent")(Consolidated Case Nos. 12-cv-954-H (RBB), 12-cv-1587-H (RBB)).

Ivera manufactures, markets, and sells the Curos® Disinfecting Port Protector, a pioneering device that disinfects and protects the entry port on certain types of valves used with intravenous lines. On August 24, 2010, the '794 patent, on an invention entitled "Medical Implement Cleaning Device," was issued by the United States Patent and Trademark Office (USPTO) followed by the issuance of the '302 patent on July 26, 2011 and the '514 patent on June 26, 2012. These three patents cover key aspects of products used to passively disinfect and protect intravenous access ports.

Catheter Connections moved for summary judgment, asking the Court to find that its DualCap Solo and Dual Cap Solo IV-Pole Strip products do not infringe any of Ivera's patents.  The Court declined, denying Catheter Connections' motion in its entirety.  "We are pleased with the Court's decision, which we believe reflects the strength of our disinfecting cap patent portfolio," said Bob Rogers, CEO of Ivera Medical. "Catheter Connections has taken many liberties with our technology and product development, and this lawsuit is just one of our actions against them.  We look forward to taking this issue to trial.  Ivera has spent significant resources on its patent portfolio and we will continue to vigorously defend our intellectual property."

About Ivera Medical
Ivera Medical Corporation, a certified Minority Business Enterprise (MBE), is focused on the design, development, manufacture, marketing and sale of products that help healthcare providers reduce facility-acquired patient infections. Curos, manufactured in Carlsbad, CA, is the first disinfecting cap to be marketed in the U.S. and has received FDA's 510(k) market clearance. For more information about Curos and Ivera Medical, visit the website at

Contact Information:

Matt Heindel
Vice President, Business Development
Ivera Medical Corp.